Get started

COMPASS Pathways Plc - American Depository Shares

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

CMPS chart

Key stats

Market capitalization
327.263MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.22USD

About COMPASS Pathways Plc - American Depository Shares

Sector
Health Technology
Industry
Biotechnology
CEO
Kabir Kumar Nath
Website
compasspathways.com
Headquarters
London
Founded
2020
ISIN
US20451W1018

Compass Pathways Plc is an investment holding company. It operates through its subsidiaries which provide mental health care services. The company was founded by Goldsmith George Jay and Malievaskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Ideas

Psilocybin for Depression Stage 3 Research $CMPS5 minutes ago Breakout Divergence Formation. Bottom Forming Around $6/share. Context: Seeing Names that are outside of the ordinary social consciousness like TSLA and Bio N Tec were until they simply began household names I see psilocybin benefitting from the wave of support for Cannabis Legalizat
Long
Psilocybin for Depression Stage 3 Research $CMPSBreakout Divergence Formation. Bottom Forming Around $6/share. Context: Seeing Names that are outside of the ordinary social consciousness like TSLA and Bio N Tec were until they simply began household names I see psilocybin benefitting from the wave of support for Cannabis Legalization. Psilocybi
Long
psychedelic is the future for mental healthpsychedelic is the future for mental health. I don't understand why the chart doesn't move but it will be because nothing else can heal the mental illness. At this moment we only have 20 years of Internet. We need to go forward. Psychotherapy doesn't work because sometimes even the client doesn't k
Long
$CMPS longOkay okay, I was way too early on this one and called it right when a bunch of Macro factors took a shit on the market. So yeah. Anyways now is the time. Thought I'd make this post since I am sampling their "product" and to correct my prior early calls. Their product is amazing and is a godsend for
Long
2
CMPS compass pathways pushing it to the limitsMagic Mushrooms. CMPS and their shrooms have been on a downward consolidation for what has felt like a year now. No edge on the weekly as price moves to test support. I, like so many others, are looking for signs of accumulation and seller exhaustion before the next step can occur.
Long
long $CMPSLooks like the MACD is still heading down but curling up. RSI is bottoming out as it reaches an important level of support. I think the risk reward at the $28 level is optimal. If you have a high risk tolerance, buy now. Shrooms are already decriminalized in Denver and are about to be in Detroit.
Long
2
$CMPS LONG from 34.40's. Profit targets set to $37 to $39Swing Long $CMPS low 34s, will add. Looking for +$4 at least. This name may bounce today (11/10/2021) for +$1 to +$2 but I'm holding for +$4. $CMPS target will be 37 to 39, Im gonna drop the first piece of $CMPS for +$2. Credit: Dan Parker (Pro trader in TrueTrader Pro Chatroom)
Long
potential 75%+ return, $CMPSCompass Pathways deals with psychedelics and their promising properties when it comes to the treatment of mental illnesses. Purple Zone: Safe Entry Green Zone: Risk Entry 76% potential return. Citron Research has a $100 PT. Citigroup has a $67 PT. Bullish MACD cross Consolidating for the pas
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Financials

Past performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.44Fabulous
Learn more
OANDA
OANDA
Forex
4.52Great
Learn more
FOREX.com
FOREX.com
Forex
4.38Fabulous
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.35Fabulous
Learn more

See all brokers 

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more